1. |
Becchetti C, Dirchwolf M, Banz V, et al. Medical management of metabolic and cardiovascular complications after liver transplantation. World J Gastroenterol, 2020, 26(18): 2138-2154.
|
2. |
Vafaei F, Dehghani SM, Malekhoseini SA, et al. Prevalence of postoperation metabolic syndrome in pediatric liver transplant patients: a single center experience. Exp Clin Transplant, 2018, 16(5): 582-587.
|
3. |
Fatourou EM, Tsochatzis EA. Management of metabolic syndrome and cardiovascular risk after liver transplantation. Lancet Gastroenterol Hepatol, 2019, 4(9): 731-741.
|
4. |
刘晓红, 李玲, 齐振华, 等. 实体器官移植术后代谢综合征及其危险因素. 中华器官移植杂志, 2019, 40(5): 313-316.
|
5. |
中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议. 中华糖尿病杂志, 2004, 12(3): 156-161.
|
6. |
Vida Perez L, Montero Alvarez JL, Poyato Gonzalez A, et al. Prevalence and predictors of metabolic syndrome after liver transplantation. Transplant Proc, 2016, 48(7): 2519-2524.
|
7. |
Thoefner LB, Rostved AA, Pommergaard HC, et al. Risk factors for metabolic syndrome after liver transplantation: a systematic review and meta-analysis. Transplant Rev (Orlando), 2018, 32(1): 69-77.
|
8. |
Jiménez-Pérez M, González-Grande R, Omonte Guzmán E, et al. Metabolic complications in liver transplant recipients. World J Gastroenterol, 2016, 22(28): 6416-6423.
|
9. |
Chang AL, Cortez AR, Bondoc A, et al. Metabolic syndrome in liver transplantation: a preoperative and postoperative concern. Surgery, 2016, 160(4): 1111-1117.
|
10. |
付俊玲, 肖新华. 代谢综合征的定义和流行病学. 临床内科杂志, 2018, 35(1): 5-9.
|
11. |
Gallagher EJ, LeRoith D. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer. Diabetes Care, 2013, 36 Suppl 2(Suppl 2): S233-S239. doi: 10.2337/dcS13-2001.
|
12. |
Mahbuba S, Mohsin F, Rahat F, et al. Descriptive epidemiology of metabolic syndrome among obese adolescent population. Diabetes Metab Syndr, 2018, 12(3): 369-374.
|
13. |
Shen T, Zhuang L, Sun XD, et al. Expert consensus on management of metabolic disease in Chinese liver transplant recipients. World J Gastroenterol, 2020, 26(27): 3851-3864.
|
14. |
Toshima T, Yoshizumi T, Inokuchi S, et al. Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation. HPB (Oxford), 2020, 22(4): 511-520.
|
15. |
Adams LA, Arauz O, Angus PW, et al. Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant. J Gastroenterol Hepatol, 2016, 31(5): 1016-1024.
|
16. |
Gebhardt S, Jara M, Malinowski M, et al. Risk factors of metabolic disorders after liver transplantation: an analysis of data from fasted patients. Transplantation, 2015, 99(6): 1243-1249.
|
17. |
Zheng J, Wang WL. Risk factors of metabolic syndrome after liver transplantation. Hepatobiliary Pancreat Dis Int, 2015, 14(6): 582-587.
|
18. |
Chhatrala R, Siddiqui MB, Stravitz RT, et al. Evolution of serum atherogenic risk in liver transplant recipients: role of lipoproteins and metabolic and inflammatory markers. Liver Transpl, 2015, 21(5): 623-630.
|
19. |
García-Pajares F, Peñas-Herrero I, Sánchez-Ocaña R, et al. Metabolic syndrome after liver transplantation: five-year prevalence and risk factors. Transplant Proc, 2016, 48(9): 3010-3012.
|
20. |
Marsano JG, Torok NJ. Metabolic syndrome post-liver transplant: can we predict? Metab Syndr Relat Disord, 2016, 14(6): 289-290.
|
21. |
Cholongitas Ε, Koukoufiki A, Pipili C, et al. Is everolimus linked to metabolic syndrome in liver transplant recipients? Indian J Gastroenterol, 2019, 38(4): 348-355.
|
22. |
Gilad O, Rabinowich L, Levy S, et al. Metabolic and renal effects of mammalian target of rapamycin inhibitors treatment after liver transplantation: real-life single-center experience. Transplant Proc, 2021, 53(1): 221-227.
|
23. |
中国医师协会器官移植医师分会, 中华医学会器官移植学分会肝移植学组. 中国肝移植受者代谢病管理专家共识(2019版). 器官移植, 2020, 11(1): 19-29.
|
24. |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版). 中华糖尿病杂志, 2021, 13(4): 315-409.
|
25. |
López-Lazcano AI, Gual A, Colmenero J, et al. Active smoking before liver transplantation in patients with alcohol use disorder: risk factors and outcomes. J Clin Med, 2020, 9(9): 2710. doi: 10.3390/jcm9092710.
|
26. |
Li Y, Nieuwenhuis LM, Werner MJM, et al. Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation. J Thromb Haemost, 2020, 18(10): 2590-2600.
|
27. |
Rice JP, Eickhoff J, Agni R, et al. Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis. Liver Transpl, 2013, 19(12): 1377-1386.
|
28. |
Wakiya T, Ishido K, Kudo D, et al. Impact of smoking cessation in donor candidates for living donor liver transplantation. Transplant Proc, 2018, 50(9): 2593-2596.
|